← back to search

Adela Alcolea-Medina

Synlab Czech (Czechia) · CZ
Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, and Gut microbiota and health.
h-index
22
citations
5,528
works
60
NIH funding
primary concept
email

Recent publications

Rapid pan-microbial metagenomics for pathogen detection and personalised therapy in the intensive care unit: a single-centre prospective observational study
The Lancet Microbe 2025cited by 12position: firstdoi
Unified metagenomic method for rapid detection of microorganisms in clinical samples
Communications Medicine 2024cited by 26position: firstdoi
The drainome: longitudinal metagenomic characterization of wastewater from hospital ward sinks to characterize the microbiome and resistome and to assess the effects of decontamination interventions
Journal of Hospital Infection 2024cited by 13position: middledoi
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study
Clinical Microbiology and Infection 2023cited by 78position: firstdoi
Routine Metagenomics Service for ICU Patients with Respiratory Infection
American Journal of Respiratory and Critical Care Medicine 2023cited by 72position: middledoi
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
Scientific Reports 2022cited by 67position: middledoi
Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
mBio 2022cited by 35position: middledoi
Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study
The Lancet Microbe 2021cited by 156position: middledoi
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Nature Microbiology 2021cited by 116position: middledoi
Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units
Genome Medicine 2021cited by 64position: middledoi
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
BMJ Open Respiratory Research 2021cited by 33position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rahul Batra · King's College London7 papers (2021–2025)Luke B. Snell · King's College London7 papers (2021–2025)Themoula Charalampous · University of East Anglia6 papers (2021–2024)Jonathan D. Edgeworth · King's College London6 papers (2021–2024)Gaia Nebbia · Guy's and St Thomas' NHS Foundation Trust6 papers (2021–2025)Christopher Alder · Guy's and St Thomas' NHS Foundation Trust5 papers (2021–2025)Penelope R. Cliff · Public Health England4 papers (2021–2024)Christopher I. S. Meadows · Guy's and St Thomas' NHS Foundation Trust3 papers (2021–2025)Tom Williams · Gene Therapy Laboratory3 papers (2021–2024)Noor Al-Yaakoubi · Guy's and St Thomas' NHS Foundation Trust3 papers (2023–2025)Gul Humayun · Guy's and St Thomas' NHS Foundation Trust3 papers (2023–2025)Duncan Wyncoll · St Thomas' Hospital3 papers (2021–2025)Simon Goldenberg · Guy's and St Thomas' NHS Foundation Trust3 papers (2023–2024)Amita Patel · Center for Biologics Evaluation and Research3 papers (2021–2023)Sam Douthwaite · West Suffolk NHS Foundation Trust2 papers (2021–2024)Richard Paúl · Institut Pasteur2 papers (2023–2025)Michael H. Malim · King's College London2 papers (2021–2022)Mark Tan Kia Ik · University of London2 papers (2021–2023)Katie J. Doores · King's College London2 papers (2021–2022)William Newsholme · Guy's and St Thomas' NHS Foundation Trust2 papers (2021–2023)